NRT Smoking Cessation Aids in Dominican Republic
Euromonitor International's NRT Smoking Cessation Aids in Dominican Republic market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 20 | Publication date: May 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
NRT gum; NRT inhalators; NRT lozenges; NRT patches; Other NRT
Table of contents
NRT SMOKING CESSATION AIDS IN DOMINICAN REPUBLIC : MARKET INSIGHT
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
LOCAL COMPANY PROFILES - DOMINICAN REPUBLIC
ETHICAL PHARMACéUTICA SA - OTC HEALTHCARE - DOMINICAN REPUBLIC
STRATEGIC DIRECTION
KEY FACTS
Summary 1 Summary - Ethical Pharmaceutical SA: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 2 Summary - Ethical Pharmaceutical SA: Competitive Position 2008
LABORATORIOS ALFA SA - OTC HEALTHCARE - DOMINICAN REPUBLIC
STRATEGIC DIRECTION
KEY FACTS
Summary 3 Summary - Laboratorios Alfa CxA: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 4 Summary - Laboratorios Alfa CxA: Competitive Position 2008
LABORATORIOS FELTREX - OTC HEALTHCARE - DOMINICAN REPUBLIC
STRATEGIC DIRECTION
KEY FACTS
Summary 5 Summary - Laboratorios Feltrex: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
LABORATORIOS MAGNACHEM CXA - OTC HEALTHCARE - DOMINICAN REPUBLIC
STRATEGIC DIRECTION
KEY FACTS
Summary 6 Summary - Laboratorios Magnachem CxA: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 7 Summary - Laboratorios Magnachem CxA: Competitive Position 2008
SUIPHARM SA - OTC HEALTHCARE - DOMINICAN REPUBLIC
STRATEGIC DIRECTION
KEY FACTS
Summary 8 Summary - Suiphar SA: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
OTC HEALTHCARE IN DOMINICAN REPUBLIC
EXECUTIVE SUMMARY
National companies increase competitiveness
Distribution companies hold important mark-ups
Slow but steady growth expected
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Penetration of Private Label by Sector 2003-2008
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Generics
Switches
DEFINITIONS
Summary 9 Summary - Research Sources